跳至主要内容
临床试验/NCT01058720
NCT01058720已完成4 期

A Pilot Study to Evaluate the Efficacy of Daily Vitamin D3 Supplementation in Normal Weight Adolescents

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2009年12月1日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
发起方
Mayo Clinic
入组人数
20
试验地点
1
主要终点
Increment in 25(OH)vitamin D level

研究概览

简要总结

The study is designed to evaluate the increment of serum 25 (OH) vitamin D levels in normal weight adolescents following a 12-week supplementation with Vitamin D3 2000 IU/day.

详细描述

Twenty normal weight adolescents between ages 12-18 that are age and gender would receive vitamin D3 supplementation at a dose of 2000 IU/day. Levels of 25(OH)vitamin D would be measured at baseline and after 12 weeks.Relationship between 25 OH vitamin D levels and other demographic variables will be assessed.The primary endpoint in this study is the 25 OH Vitamin D level at 12 weeks.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
12 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Subjects between ages 12 and 18 years with BMI between the 5th and the 85th percentile for age and gender.

排除标准

  • •Subjects with 25 (OH)- D levels >80 ng/mL
  • •Serum calcium >10.8 mg/dL
  • •Serum phosphorus > 5.5 mg/dl
  • •Pregnancy or nursing
  • •Current cancer
  • •Patients on multivitamin supplementation
  • •Dietary calcium intake exceeding 1500 mg/day
  • •Hepatic or renal disorders
  • •Type 1 or Type 2 diabetes mellitus
  • •Those receiving insulin, metformin, or oral hypoglycemic medications
  • •Malabsorption disorders (Celiac disease, Cystic fibrosis, Inflammatory bowel disease)

研究组 & 干预措施

Vitamin D3

Experimental

Patients would receive 2000 IU of vitamin D3 daily for 12 weeks

干预措施: Vitamin D3 (Dietary Supplement)

结局指标

主要结局

Increment in 25(OH)vitamin D level

时间窗: 12 weeks

次要结局

  • Serum Calcium(12 weeks)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Seema Kumar

PI

Mayo Clinic

研究点 (1)

Loading locations...

相似试验